Carlsmed (CARL) Cash from Financing Activities (2024 - 2026)

Carlsmed's Cash from Financing Activities history runs 3 years deep, the most recent figure standing at $436000.0 for Q1 2026.

• Quarterly Cash from Financing Activities fell 96.27% year-over-year to $436000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88.9 million (changed N/A YoY) and the FY2025 annual result came in at $100.1 million, up 71.16% from the prior year.
• Cash from Financing Activities was $436000.0 for Q1 2026 at Carlsmed, up from -$29000.0 in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $90.7 million in Q3 2025 and bottomed at -$2.2 million in Q2 2025.
• A 3-year average of $16.3 million and a median of $436000.0 in 2026 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2025 — Cash from Financing Activities soared 551.41% — and 2026, when it sank 96.27%.
• Carlsmed's Cash from Financing Activities stood at -$51000.0 in 2024, then soared by 43.14% to -$29000.0 in 2025, then jumped by 1603.45% to $436000.0 in 2026.
• Business Quant data shows CARL's Cash from Financing Activities at $436000.0 in Q1 2026, -$29000.0 in Q4 2025, and $90.7 million in Q3 2025.